JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

EGFR

A8199 PD153035 hydrochloride
1 Citation

Target: EGFR

Summary: Potent EGFR inhibitor

insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
A8197 Compound 56
1 Citation

Target: EGFR

Summary: REGFR inhibitor

insoluble in H2O; ≥16.95 mg/mL
A5455 AEE788 (NVP-AEE788)

Summary: EGFR/HER-2/VEGFR inhibitor

≥22.05 mg/mL
A4139 AG-490
3 Citation

Target: EGFR|JAK

Summary: JAK2/EGFR inhibitor

insoluble in H2O; ≥14.7 mg/mL
A4092 CUDC-101
1 Citation

Target: Histone Deacetylases (HDACs)|EGFR|ErbB

Summary: Multitargeted HDAC inhibitor

≥21.7 mg/mL
A3967 Lapatinib Ditosylate

Target: EGFR|ErbB-2

Summary: EGFR/HER2 inhibitor,potent and selective

≥24.3 mg/mL
A3482 Icotinib Hydrochloride

Summary: EGFR inhibitor,potent and specific

Soluble in DMSO
A3433 Gefitinib hydrochloride

Target: EGFR

Summary: Potent EGFR inhibitor

insoluble in EtOH; ≥4.28 mg/mL
A3397 Erlotinib
4 Citation

Summary: EGFR tyrosine kinase inhibitor

insoluble in H2O; ≥19.65 mg/mL
A3320 CO-1686 (AVL-301)
1 Citation

Target: EGFR

Summary: EGFR inhibitor

≥27.8 mg/mL